{"meta":{"query_hash":"1a7453412365","filters":{"venue":"Biologics"},"cohort_total":20,"direct_labels_cover":0,"predictions_cover":20,"exported":20,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1a7453412365","api":"https://metacan.xera.ac/api/v1/cohort?venue=Biologics"},"results":[{"id":"W1971365073","doi":"10.2147/btt.s6748","title":"Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib","year":2010,"lang":"en","type":"article","venue":"Biologics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Sunitinib; Sorafenib; Everolimus; Medicine; Internal medicine; Oncology; Renal cell carcinoma; Urology","score_opus":0.01719074779736497,"score_gpt":0.24529601222092892,"score_spread":0.22810526442356396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971365073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634206,0.00036337815,0.0000113226315,0.0009898831,0.00015837718,0.0018103401,0.00008375453,0.000034212215,0.0002066587],"genre_scores_gemma":[0.9953498,0.00007596783,0.0023089023,0.00057620264,0.00019549722,0.0007690833,0.00008370572,0.000020772733,0.00062001985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991475,0.000016248643,0.0001460607,0.00032595743,0.00011010598,0.0002541466],"domain_scores_gemma":[0.9992304,0.000106806205,0.000092590526,0.00032341553,0.00017086937,0.000075923715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009101049,0.00018706785,0.00020886144,0.000023845774,0.000102885824,0.000013499856,0.000080736136,0.00007777848,0.000046379497],"category_scores_gemma":[0.000078481855,0.00007778979,0.00004627358,0.00007465057,0.00014501548,0.000035274366,0.000039414528,0.00016320613,0.0000037000113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026015945,0.0014495377,0.908598,0.00047658055,0.00022045492,0.000043315766,0.0008526618,0.000009778032,0.01760475,0.000042348325,0.0027100022,0.041976612],"study_design_scores_gemma":[0.006593572,0.004921584,0.86805785,0.000064259555,0.00023830635,0.00001370925,0.00007951398,0.000024664048,0.023750506,0.000040786013,0.09592127,0.0002939589],"about_ca_topic_score_codex":0.000021571383,"about_ca_topic_score_gemma":0.00024332081,"teacher_disagreement_score":0.09321127,"about_ca_system_score_codex":0.000031347736,"about_ca_system_score_gemma":0.00007082254,"threshold_uncertainty_score":0.31721753},"labels":[],"label_agreement":null},{"id":"W1983465503","doi":"10.2147/btt.s55196","title":"Therapeutic vaccines and cancer: focus on DPX-0907","year":2014,"lang":"en","type":"review","venue":"Biologics","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Immunovaccine (Canada); Dalhousie University","funders":"","keywords":"Immune system; Immunogenicity; Antigen; Vaccination; Cancer vaccine; Medicine; Immunology; Cancer; Prostate cancer; Ovarian cancer; Immunotherapy; Internal medicine","score_opus":0.05137077056622755,"score_gpt":0.32996260898802704,"score_spread":0.27859183842179946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983465503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008695907,0.99717385,0.000012402507,0.00010198402,0.0013562577,0.0005620926,0.0000870879,0.000118300864,0.0005010598],"genre_scores_gemma":[0.0003220982,0.9948597,0.0000076628885,0.0003079081,0.00011794474,0.00015926184,0.00013341021,0.000049627295,0.0040423996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99745864,0.0009753676,0.0005327646,0.0005353235,0.000024200677,0.00047370544],"domain_scores_gemma":[0.9981197,0.0009152444,0.00038648144,0.00052275154,0.00003837643,0.000017428209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003665475,0.000618158,0.0018205526,0.00018138652,0.00024750875,0.000027518165,0.00044533052,0.0012322947,0.0004091238],"category_scores_gemma":[0.00008489953,0.00037013044,0.00037892378,0.00014940732,0.00022410613,0.000025455522,0.00010842426,0.0006334104,0.0006241731],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013155698,0.00004924136,0.000013390687,0.00072037615,0.0005664077,0.0000017075469,0.000021507183,3.9538996e-8,0.00026824177,0.0010079417,0.0009554918,0.9962641],"study_design_scores_gemma":[0.00043330019,0.00065287034,0.00004469511,0.0019272877,0.00032565254,0.000082921455,0.00000847109,7.417013e-8,0.00019416439,0.00018954684,0.9956745,0.000466521],"about_ca_topic_score_codex":0.000054410277,"about_ca_topic_score_gemma":0.0000047965846,"teacher_disagreement_score":0.9957976,"about_ca_system_score_codex":0.000055079017,"about_ca_system_score_gemma":0.00012807282,"threshold_uncertainty_score":0.99987507},"labels":[],"label_agreement":null},{"id":"W2022859954","doi":"10.2147/btt.s1834","title":"Sunitinib for advanced renal cell cancer","year":2008,"lang":"en","type":"article","venue":"Biologics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Sunitinib; Medicine; Oncology; Tyrosine-kinase inhibitor; Internal medicine; Cancer; Kidney cancer; Pharmacology","score_opus":0.09144051966007616,"score_gpt":0.31365842360725577,"score_spread":0.2222179039471796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022859954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903958,0.0016818823,0.00014025375,0.00030129112,0.00012601005,0.0004868327,0.00004590062,0.00005724592,0.006764823],"genre_scores_gemma":[0.9880205,0.00070045964,0.005396563,0.00046666,0.00019237303,0.00014506093,0.000121207624,0.000011998818,0.0049451753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940294,0.000013680544,0.00012643445,0.00018438794,0.00006956817,0.0002030063],"domain_scores_gemma":[0.99955726,0.000066946675,0.000051126357,0.00015831603,0.00008516949,0.00008118035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004398618,0.00010894802,0.00018621412,0.000027846501,0.00007332934,0.0000017887771,0.000047151843,0.00007868212,0.00008883451],"category_scores_gemma":[0.000036565605,0.00007187821,0.00009353843,0.00006109065,0.00006100651,0.000014790566,0.00001627853,0.00006155318,0.000024358997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027557006,0.00084939855,0.13008656,0.00023918123,0.00016541965,0.00057990634,0.00044794998,0.00009861587,0.7998873,0.00040664434,0.028120706,0.03636262],"study_design_scores_gemma":[0.0050334013,0.0034142446,0.09570865,0.00004523252,0.00012163673,0.0001527811,0.00009107694,0.00005118363,0.68369406,0.00015865473,0.2112356,0.000293501],"about_ca_topic_score_codex":0.000019437324,"about_ca_topic_score_gemma":0.000004538389,"teacher_disagreement_score":0.18311489,"about_ca_system_score_codex":0.00007755626,"about_ca_system_score_gemma":0.00008593849,"threshold_uncertainty_score":0.29311082},"labels":[],"label_agreement":null},{"id":"W2024124694","doi":"10.2147/btt.s2372","title":"Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells","year":2008,"lang":"en","type":"article","venue":"Biologics","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Medicine; Gastrointestinal tract; Disease; Cell; Immunology; Internal medicine; Biology","score_opus":0.025908596585883903,"score_gpt":0.24696553339602761,"score_spread":0.2210569368101437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024124694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963392,0.0013538864,0.000044529494,0.000018689138,0.0012363256,0.0003869153,0.00018749275,0.000045814035,0.00038714978],"genre_scores_gemma":[0.9938727,0.003995106,0.00077132584,0.00013676242,0.00043109176,0.0000071129143,0.00043521237,0.000039448107,0.00031121465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982816,0.00024206607,0.0005031385,0.00044904996,0.000106271094,0.0004178942],"domain_scores_gemma":[0.9989285,0.00003999634,0.00036530587,0.00029507058,0.0002523473,0.00011880629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002062287,0.00028307625,0.0003812217,0.00006290644,0.00015066193,0.000010658747,0.00026114078,0.000716048,0.00008288366],"category_scores_gemma":[0.000033066444,0.00023259824,0.00015450046,0.0001221315,0.00027024778,0.0000050361473,0.00016327278,0.00014906454,0.000048356836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041127877,0.00016953058,0.0034135727,0.000045112927,0.000092098504,0.000013535308,0.00030218682,0.000016102376,0.99456376,0.0000059019394,0.0008802708,0.00008662708],"study_design_scores_gemma":[0.0012127706,0.0014021425,0.0040500187,0.000037127546,0.00003436229,0.000026662552,0.00014616486,0.00001900809,0.9711371,0.000007010775,0.02159167,0.00033596545],"about_ca_topic_score_codex":0.000104522514,"about_ca_topic_score_gemma":0.000011247259,"teacher_disagreement_score":0.023426687,"about_ca_system_score_codex":0.000040240244,"about_ca_system_score_gemma":0.00026618887,"threshold_uncertainty_score":0.9485081},"labels":[],"label_agreement":null},{"id":"W2024383628","doi":"10.2147/btt.2009.3580","title":"A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase","year":2009,"lang":"en","type":"review","venue":"Biologics","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Center for Research Resources; BioMarin Pharmaceutical","keywords":"Enzyme replacement therapy; Mucopolysaccharidosis; Medicine; SciELO; Intensive care medicine; Quality of life (healthcare); MEDLINE; Placebo; Pediatrics; Physical therapy; Internal medicine; Pathology; Alternative medicine; Biology; Disease","score_opus":0.06078147016024177,"score_gpt":0.379615220554129,"score_spread":0.3188337503938872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024383628","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017374345,0.98970133,0.000009429897,0.00024727685,0.000048390062,0.007952231,0.000032095613,0.000019037592,0.0019728595],"genre_scores_gemma":[0.00008246419,0.99869514,0.00028184708,0.00022765461,0.000023189048,0.00039496704,0.00005650301,0.000023968481,0.00021428333],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960657,0.0007101074,0.0016488363,0.00046130113,0.000747716,0.00036634272],"domain_scores_gemma":[0.99701035,0.00037352688,0.0009991128,0.0014367708,0.00009047636,0.000089753055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016049294,0.00046421803,0.0041844025,0.00029445402,0.000027774793,0.000009552517,0.001119283,0.0002761184,0.00007945531],"category_scores_gemma":[0.0007767022,0.00022643572,0.0007703536,0.0012439948,0.00009691105,0.00003687971,0.00016434361,0.00045390474,0.000050600327],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014744772,0.000234866,0.0000018794452,0.77549416,0.00022097066,0.0002057225,0.00001554034,5.65089e-8,1.690865e-7,0.00035743965,0.00020492866,0.22324955],"study_design_scores_gemma":[0.00036598716,0.0010459555,0.000013402708,0.9543458,0.0022759424,0.00016494912,0.00008895146,4.756134e-7,0.00000145252,0.00024098333,0.041246343,0.00020973086],"about_ca_topic_score_codex":0.000044395238,"about_ca_topic_score_gemma":0.000003101867,"teacher_disagreement_score":0.22303982,"about_ca_system_score_codex":0.00017194943,"about_ca_system_score_gemma":0.00019109786,"threshold_uncertainty_score":0.92337805},"labels":[],"label_agreement":null},{"id":"W2035860257","doi":"10.2147/btt.s61600","title":"Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia","year":2015,"lang":"en","type":"review","venue":"Biologics","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Obinutuzumab; Chemoimmunotherapy; Rituximab; Medicine; Chronic lymphocytic leukemia; CD20; Monoclonal antibody; Oncology; Immunology; Monoclonal antibody therapy; Lymphoma; Ofatumumab; Leukemia; Antibody","score_opus":0.0957161881886593,"score_gpt":0.4039952895686591,"score_spread":0.3082791013799998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035860257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030266486,0.9659301,7.279992e-7,0.0000014897548,0.00009433296,0.0027831367,0.0001047205,0.000015829168,0.000803161],"genre_scores_gemma":[0.006885139,0.9920241,0.0001115534,0.000012091241,0.00020185745,0.00016739016,0.00044623285,0.00003697906,0.00011464498],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965688,0.0005781177,0.0012976225,0.0005143928,0.00059459347,0.00044645916],"domain_scores_gemma":[0.9968685,0.0009290796,0.00071487355,0.0010776857,0.000281922,0.00012793203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079693284,0.00045368003,0.0029458369,0.00017265989,0.000021181108,0.0000060040534,0.0004970925,0.00067424047,0.000025922902],"category_scores_gemma":[0.00026270622,0.00019577408,0.0005339599,0.0005410069,0.000586777,0.000020391226,0.00008941787,0.00029810608,0.00003850409],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0004721732,0.00046948847,0.0011937448,0.0057463837,0.0005142384,0.000075119206,0.00023797952,0.000014622952,1.5743333e-7,0.00005971372,0.00019255288,0.99102384],"study_design_scores_gemma":[0.021366445,0.015537165,0.0003014149,0.0059444834,0.0011605107,0.00007202468,0.00008738856,0.00026976972,0.0000032442074,0.000031234038,0.95496935,0.00025695993],"about_ca_topic_score_codex":0.0008989163,"about_ca_topic_score_gemma":0.00005659183,"teacher_disagreement_score":0.9907669,"about_ca_system_score_codex":0.18156621,"about_ca_system_score_gemma":0.12027217,"threshold_uncertainty_score":0.8847151},"labels":[],"label_agreement":null},{"id":"W2043209924","doi":"10.2147/btt.s24220","title":"Role of vandetanib in the management of medullary thyroid cancer","year":2012,"lang":"en","type":"article","venue":"Biologics","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre hospitalier de l'Université Laval; Université de Montréal; Centre hospitalier universitaire de Québec","funders":"","keywords":"Vandetanib; Medullary thyroid cancer; Medullary cavity; Medicine; Thyroid cancer; Cancer; Internal medicine; Oncology; Receptor","score_opus":0.02566177312025661,"score_gpt":0.2995599205318564,"score_spread":0.2738981474115998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043209924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95308363,0.04058244,0.0000021080602,0.0003376877,0.00006642143,0.00027949718,0.000014877212,0.000005505941,0.0056277993],"genre_scores_gemma":[0.9904443,0.008942562,0.00027354844,0.00017764546,0.000047946556,0.00007101079,0.000007765852,0.0000034083864,0.000031830758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995212,0.00002650893,0.00014813698,0.0000716352,0.00009919921,0.00013331012],"domain_scores_gemma":[0.99969304,0.000031187414,0.00006465951,0.0001701475,0.00001741646,0.000023575634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016966942,0.00006506071,0.00016004514,0.000022764749,0.0000094858015,8.7227875e-7,0.000069667454,0.000039413837,0.000052999887],"category_scores_gemma":[0.0000033304539,0.00003303567,0.00005032331,0.00010425506,0.000036930418,0.0000146818375,0.000026033122,0.000041419844,0.0000028480042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010324876,0.00092469814,0.96116054,0.00011007098,0.00020516073,0.0000059997233,0.00070014154,0.0000058009646,0.005709745,0.006283406,0.0005756858,0.024215505],"study_design_scores_gemma":[0.00077531405,0.00029073286,0.97608316,0.00008217741,0.00013172811,0.0000032762596,0.0013667837,0.0000026939183,0.012107485,0.00022792214,0.008881509,0.00004722619],"about_ca_topic_score_codex":0.00009457531,"about_ca_topic_score_gemma":0.000018345418,"teacher_disagreement_score":0.037360616,"about_ca_system_score_codex":0.00003588719,"about_ca_system_score_gemma":0.000011549953,"threshold_uncertainty_score":0.13471556},"labels":[],"label_agreement":null},{"id":"W2080246280","doi":"10.2147/btt.s24734","title":"B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms","year":2012,"lang":"en","type":"article","venue":"Biologics","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"University of Alberta; Ministry of Agriculture - Saskatchewan","keywords":"Pathogenesis; Antibody; Immunology; Autoantibody; Antigen; Antigen presentation; B cell; Biology; Medicine; T cell; Immune system","score_opus":0.018031149985900375,"score_gpt":0.2594838414677435,"score_spread":0.24145269148184312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080246280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97264993,0.011704503,0.009163267,0.00030242244,0.0037892149,0.00065139116,0.00029634836,0.00022157095,0.0012213348],"genre_scores_gemma":[0.9934461,0.0018979001,0.0010168203,0.001046334,0.00012043293,0.000033162014,0.00037608767,0.000031349,0.002031816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99724597,0.00038271313,0.00047706204,0.0006215372,0.00006756355,0.001205129],"domain_scores_gemma":[0.99891096,0.00018648226,0.00019432948,0.00050857937,0.000100404824,0.00009924201],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063145056,0.00044913337,0.00064791477,0.000104383544,0.00037502477,0.0000309238,0.00035590495,0.0008679769,0.0004563856],"category_scores_gemma":[0.00007714423,0.00034162862,0.00014041954,0.00016720999,0.0002338776,0.00014806073,0.0005362539,0.00036934428,0.002070477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001387791,0.00030854414,0.005053959,0.000013807824,0.00017411784,0.000014804226,0.0002767441,0.0000012542263,0.98587567,0.006294866,0.0008094579,0.001037995],"study_design_scores_gemma":[0.0012161813,0.0006102568,0.0056539522,0.000017409762,0.00008931574,0.00024012325,0.0003305989,5.5899676e-7,0.90622467,0.0009197141,0.08417212,0.0005251159],"about_ca_topic_score_codex":0.0001657615,"about_ca_topic_score_gemma":0.000016321592,"teacher_disagreement_score":0.08336266,"about_ca_system_score_codex":0.00005646903,"about_ca_system_score_gemma":0.000037142574,"threshold_uncertainty_score":0.99990356},"labels":[],"label_agreement":null},{"id":"W2163182875","doi":"10.2147/btt.s19099","title":"Gut microbiota: next frontier in understanding human health and development of biotherapeutics","year":2011,"lang":"en","type":"article","venue":"Biologics","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":254,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Fonds Québécois de la Recherche sur la Nature et les Technologies","keywords":"Gut flora; Dysbiosis; Human health; Disease; Biology; Microbiome; Immunology; Medicine; Computational biology; Biotechnology; Bioinformatics; Environmental health; Pathology","score_opus":0.2195514684969642,"score_gpt":0.31744924995802803,"score_spread":0.09789778146106384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163182875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943437,0.0029289166,0.0021463025,0.000049869188,0.00007691214,0.00017163485,0.000009351322,0.0000069091707,0.00026640878],"genre_scores_gemma":[0.98702145,0.0008203387,0.011561707,0.0004663213,0.00002046339,0.000002208762,0.00006423743,0.000009722129,0.00003356989],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99917567,0.00004840631,0.00028659188,0.00022518636,0.000025540012,0.0002385804],"domain_scores_gemma":[0.9996634,0.0000032699663,0.00011576117,0.0001370607,0.000016933192,0.00006354029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020965417,0.00011533742,0.00017516065,0.000057974605,0.000083454535,0.0000053000113,0.00009600141,0.00016325005,0.000010611547],"category_scores_gemma":[0.0000056599324,0.00009907618,0.000022098384,0.000052439984,0.00010477518,0.0000020885814,0.00007390188,0.000066258406,0.0000014324746],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037478723,0.00008449741,0.04330519,0.00005619177,0.000022010527,4.9152453e-7,0.0012477288,9.3101754e-8,0.9528065,0.0005378543,0.0002567669,0.0016452012],"study_design_scores_gemma":[0.0042764125,0.0036918146,0.6536525,0.00026822297,0.000018304105,0.000042274416,0.014729865,0.000007247391,0.20326932,0.0019846582,0.11659685,0.0014625527],"about_ca_topic_score_codex":0.0000348932,"about_ca_topic_score_gemma":0.00025629828,"teacher_disagreement_score":0.74953717,"about_ca_system_score_codex":0.000051450537,"about_ca_system_score_gemma":0.00016559233,"threshold_uncertainty_score":0.40402094},"labels":[],"label_agreement":null},{"id":"W2168849655","doi":"10.2147/btt.s1832","title":"Erlotinib in the treatment of advanced pancreatic cancer","year":2008,"lang":"en","type":"article","venue":"Biologics","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Gemcitabine; Pancreatic cancer; Medicine; Oncology; Internal medicine; Erlotinib Hydrochloride; Malignancy; Epidermal growth factor receptor; Clinical trial; Cancer; Chemotherapy; EGFR inhibitors; Targeted therapy; Tyrosine-kinase inhibitor; Cabozantinib; Pharmacology","score_opus":0.11071018200816875,"score_gpt":0.39854782635781943,"score_spread":0.2878376443496507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168849655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139845,0.0025828164,0.0000057817106,0.0006349331,0.000033047094,0.00053682906,0.000007659509,0.000010289007,0.0047902176],"genre_scores_gemma":[0.9816365,0.016283004,0.00070095586,0.00018969696,0.000058245965,0.0001536056,0.0000103489765,0.0000035732683,0.0009640432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993532,0.00008413196,0.00017424359,0.00011437295,0.00010060467,0.00017348371],"domain_scores_gemma":[0.9994182,0.0002762982,0.000045564353,0.00018968487,0.000038571274,0.000031661726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012554467,0.0000765279,0.0003408789,0.00003972737,0.000039037754,7.2971994e-7,0.00006878192,0.000072794894,0.000104349],"category_scores_gemma":[0.00009369633,0.000035951005,0.0000523567,0.00015061641,0.00019394024,0.000009192496,0.0000062856407,0.000058877627,0.0000117093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002502556,0.00052927365,0.98974174,0.000014334745,0.00003675985,0.00007423127,0.0012452578,0.0000029297642,0.0015270198,0.00012571044,0.00017301663,0.0062794858],"study_design_scores_gemma":[0.001763536,0.0028694377,0.98420656,0.000026173839,0.000053120577,0.000052203035,0.0004641391,0.000059222708,0.0005937996,0.00008378114,0.00978193,0.000046100864],"about_ca_topic_score_codex":0.00023363647,"about_ca_topic_score_gemma":0.000053850392,"teacher_disagreement_score":0.013700187,"about_ca_system_score_codex":0.0000744969,"about_ca_system_score_gemma":0.00014427495,"threshold_uncertainty_score":0.14660394},"labels":[],"label_agreement":null},{"id":"W2294831438","doi":"10.2147/btt.s71679","title":"Selective biologics for ulcerative colitis and Crohn's disease - clinical utility of vedolizumab","year":2016,"lang":"en","type":"review","venue":"Biologics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Vedolizumab; Ulcerative colitis; Medicine; Crohn's disease; Dermatology; Gastroenterology; Disease; Internal medicine","score_opus":0.06380168037548088,"score_gpt":0.37830337628042615,"score_spread":0.31450169590494526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294831438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004974059,0.9836888,0.00042765003,0.000011979063,0.0004127307,0.002645267,0.007489345,0.000030577456,0.0003196486],"genre_scores_gemma":[0.0054684747,0.9918188,0.000332249,0.000071714996,0.0005566278,0.0003570517,0.0011602975,0.000040069608,0.00019470278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99674875,0.0008475652,0.0009273599,0.00097503635,0.00008505251,0.0004162215],"domain_scores_gemma":[0.99772155,0.00033854638,0.00070336997,0.0006123246,0.00034064858,0.00028354605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074980647,0.0005266432,0.0012684476,0.000053566444,0.00011282426,0.000016820273,0.0003615587,0.0010355377,0.000021070664],"category_scores_gemma":[0.0023095214,0.00034110385,0.00079353113,0.00007119445,0.00084938284,0.000003971609,0.00031861593,0.00018636558,0.000007999578],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003031802,0.00029432197,0.00271993,0.007833859,0.0007898008,0.000074804,0.000009776099,7.906543e-8,0.000015101864,0.0012609273,0.005158498,0.9788111],"study_design_scores_gemma":[0.0007334973,0.00054067257,0.051438853,0.0010027693,0.0004140284,0.0000058969854,0.000007097199,0.0000039442943,0.000016057622,0.0008562108,0.9443933,0.0005877214],"about_ca_topic_score_codex":0.0000013746549,"about_ca_topic_score_gemma":0.0000078291105,"teacher_disagreement_score":0.9782234,"about_ca_system_score_codex":0.000031347925,"about_ca_system_score_gemma":0.0008560128,"threshold_uncertainty_score":0.9999041},"labels":[],"label_agreement":null},{"id":"W3119939393","doi":"10.2147/btt.s285610","title":"Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab","year":2021,"lang":"en","type":"article","venue":"Biologics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Discontinuation; Medicine; Biosimilar; Infliximab; Psoriatic arthritis; Rheumatoid arthritis; Internal medicine; Population; Disease","score_opus":0.0265783013926262,"score_gpt":0.2985141961853323,"score_spread":0.27193589479270613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119939393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959122,0.00018439826,0.0004872261,0.0009942164,0.00081863755,0.00069762085,0.00026748696,0.00016696754,0.000471236],"genre_scores_gemma":[0.99291945,0.00016078311,0.0015761731,0.0035615002,0.00010739527,0.00006335692,0.00028647488,0.000048108453,0.0012767366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964386,0.0006964817,0.0007042068,0.0011571504,0.00015435865,0.00084920734],"domain_scores_gemma":[0.9979575,0.0004853444,0.00029502262,0.0007384563,0.0003248489,0.00019879911],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073413696,0.00060030166,0.00083603885,0.00023462967,0.00038760138,0.00014930312,0.00038512077,0.00081749354,0.0003657006],"category_scores_gemma":[0.0013409767,0.00040861688,0.00013948957,0.0005001848,0.00017341494,0.00027036617,0.00028981012,0.0006570338,0.00006451098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066160094,0.0051463703,0.6744809,0.00019653817,0.00094417523,0.00017435012,0.0018399064,0.00003132502,0.2129419,0.01306459,0.00397255,0.08059136],"study_design_scores_gemma":[0.009703467,0.009788986,0.4483771,0.00060532906,0.00027191895,0.000023086193,0.0010025285,0.00023508648,0.40600467,0.0011265987,0.120697536,0.0021636921],"about_ca_topic_score_codex":0.000059308393,"about_ca_topic_score_gemma":0.00014273696,"teacher_disagreement_score":0.22610381,"about_ca_system_score_codex":0.00018201074,"about_ca_system_score_gemma":0.00012461259,"threshold_uncertainty_score":0.99983656},"labels":[],"label_agreement":null},{"id":"W3158426855","doi":"10.2147/btt.s292692","title":"Baculoviruses in Gene Therapy and Personalized Medicine","year":2021,"lang":"en","type":"review","venue":"Biologics","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Genetic enhancement; Biosafety; Gene delivery; Tropism; Personalized medicine; Regenerative medicine; Biology; Gene; Computational biology; Vector (molecular biology); Virology; Virus; Medicine; Bioinformatics; Recombinant DNA; Stem cell; Biotechnology; Genetics","score_opus":0.10940486840089599,"score_gpt":0.37917405141318195,"score_spread":0.269769183012286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158426855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001857018,0.9972488,0.000010660293,0.00001702172,0.00023199739,0.00027428623,0.00006983136,0.000010503042,0.00027983464],"genre_scores_gemma":[0.00013088058,0.9977533,0.00009222586,0.0003574891,0.00047599192,0.00008418441,0.00069421285,0.00002577367,0.00038593492],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860907,0.00026223733,0.00031758798,0.00053584157,0.00007025863,0.00020500743],"domain_scores_gemma":[0.99940383,0.000037215483,0.0001458061,0.00029366536,0.000040716084,0.000078762256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015771703,0.00032110835,0.00081955735,0.000063221894,0.00005307097,0.000016438398,0.00015297756,0.00048977305,0.00011617976],"category_scores_gemma":[0.0001502735,0.00020336245,0.00021519589,0.00013210827,0.00017883733,0.0000012373567,0.00014870719,0.00013933462,0.000004694502],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040214385,0.00013369264,0.00037190487,0.0011983638,0.00024469415,0.00004585657,0.000028678834,6.3674696e-7,0.003582409,0.0001939918,0.014411098,0.9797485],"study_design_scores_gemma":[0.00035312786,0.0002876783,0.000025114323,0.0009936878,0.00004350279,0.000042374617,0.000015243515,2.4446962e-7,0.00012290721,0.0000296642,0.99782646,0.00025997046],"about_ca_topic_score_codex":0.000027148348,"about_ca_topic_score_gemma":0.000007955904,"teacher_disagreement_score":0.98341537,"about_ca_system_score_codex":0.000013751224,"about_ca_system_score_gemma":0.00011882693,"threshold_uncertainty_score":0.829288},"labels":[],"label_agreement":null},{"id":"W3197380371","doi":"10.2147/btt.s259124","title":"Stem Cell Therapy for Burns: Story so Far","year":2021,"lang":"en","type":"review","venue":"Biologics","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Sunnybrook Hospital","funders":"","keywords":"Stem cell; Mesenchymal stem cell; Wound healing; Adult stem cell; Medicine; Stem cell transplantation for articular cartilage repair; Clinical uses of mesenchymal stem cells; Stem-cell therapy; Cell biology; Microvesicles; Exosome; Embryonic stem cell; Cancer research; Immunology; Biology; microRNA","score_opus":0.288923167243716,"score_gpt":0.4361278721146202,"score_spread":0.1472047048709042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197380371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013966651,0.9930452,0.00012141663,0.00006631612,0.00040706442,0.003179102,0.00009546484,0.00006962606,0.003001819],"genre_scores_gemma":[0.0000022449049,0.9702946,0.00044069762,0.00019173512,0.000607885,0.00043696375,0.0005154959,0.00006292482,0.027447458],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975381,0.00047107105,0.00048680278,0.0006641828,0.00029819558,0.00054163183],"domain_scores_gemma":[0.9976861,0.00092656666,0.0002534538,0.0006961673,0.00023116144,0.00020657017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010496029,0.00043969226,0.0021608889,0.0001339243,0.00013605072,0.00003912297,0.00035228775,0.0008714295,0.00062998873],"category_scores_gemma":[0.000115971765,0.00026230075,0.0009222576,0.00027494377,0.00016198316,0.000010933652,0.00009470815,0.00072561123,0.00019936248],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001873209,0.000108522814,0.0000060953553,0.012018971,0.00013166999,0.00006195282,0.000016552836,2.2163663e-8,0.000035218032,0.00009851537,0.010081251,0.9774225],"study_design_scores_gemma":[0.00040607137,0.0007839034,0.0000017001724,0.0027152551,0.00017308998,0.000035002617,0.00006119787,0.0000014047757,0.00004129126,0.00000407657,0.9955116,0.00026544151],"about_ca_topic_score_codex":0.0000048633465,"about_ca_topic_score_gemma":9.4399644e-7,"teacher_disagreement_score":0.9854303,"about_ca_system_score_codex":0.00018815161,"about_ca_system_score_gemma":0.0012596102,"threshold_uncertainty_score":0.9999829},"labels":[],"label_agreement":null},{"id":"W4240113361","doi":"10.2147/btt.s3766","title":"A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase","year":2009,"lang":"en","type":"review","venue":"Biologics","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Enzyme replacement therapy; Mucopolysaccharidosis; Medicine; SciELO; Quality of life (healthcare); MEDLINE; Intensive care medicine; Pediatrics; Physical therapy; Internal medicine; Disease; Biology","score_opus":0.06078147016024177,"score_gpt":0.379615220554129,"score_spread":0.3188337503938872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240113361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017374345,0.98970133,0.000009429897,0.00024727685,0.000048390062,0.007952231,0.000032095613,0.000019037592,0.0019728595],"genre_scores_gemma":[0.00008246419,0.99869514,0.00028184708,0.00022765461,0.000023189048,0.00039496704,0.00005650301,0.000023968481,0.00021428333],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960657,0.0007101074,0.0016488363,0.00046130113,0.000747716,0.00036634272],"domain_scores_gemma":[0.99701035,0.00037352688,0.0009991128,0.0014367708,0.00009047636,0.000089753055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016049294,0.00046421803,0.0041844025,0.00029445402,0.000027774793,0.000009552517,0.001119283,0.0002761184,0.00007945531],"category_scores_gemma":[0.0007767022,0.00022643572,0.0007703536,0.0012439948,0.00009691105,0.00003687971,0.00016434361,0.00045390474,0.000050600327],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014744772,0.000234866,0.0000018794452,0.77549416,0.00022097066,0.0002057225,0.00001554034,5.65089e-8,1.690865e-7,0.00035743965,0.00020492866,0.22324955],"study_design_scores_gemma":[0.00036598716,0.0010459555,0.000013402708,0.9543458,0.0022759424,0.00016494912,0.00008895146,4.756134e-7,0.00000145252,0.00024098333,0.041246343,0.00020973086],"about_ca_topic_score_codex":0.000044395238,"about_ca_topic_score_gemma":0.000003101867,"teacher_disagreement_score":0.22303982,"about_ca_system_score_codex":0.00017194943,"about_ca_system_score_gemma":0.00019109786,"threshold_uncertainty_score":0.92337805},"labels":[],"label_agreement":null},{"id":"W4322383175","doi":"10.2147/btt.s4964","title":"Potentials and limitations of microorganisms as renal failure biotherapeutics","year":2009,"lang":"en","type":"article","venue":"Biologics","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Dialysis; Medicine; Transplantation; Artificial kidney; Uremia; Pharmacology; Chemistry; Intensive care medicine; Internal medicine","score_opus":0.020207635790364383,"score_gpt":0.247989531296974,"score_spread":0.2277818955066096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322383175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910146,0.004598276,0.0021679404,0.0006842468,0.00005216743,0.00011315801,0.000021691794,0.000008376091,0.0013395193],"genre_scores_gemma":[0.98827314,0.0043634055,0.0061127124,0.0008816898,0.000057465473,0.000001268507,0.00006921727,0.0000050595986,0.00023606092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99949753,0.000033803317,0.00013731043,0.00017140113,0.00004300983,0.0001169504],"domain_scores_gemma":[0.9996806,0.000011628576,0.000062693216,0.0001586765,0.000049379716,0.000037037174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007909545,0.00009013769,0.00010538123,0.000022779639,0.000037023052,0.000009508673,0.00009658514,0.00014029062,0.000011039911],"category_scores_gemma":[0.00009274626,0.00007300104,0.000040162933,0.000053682583,0.00008995911,0.0000011385155,0.000026164947,0.000029377647,0.000003967776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016887145,0.000036616726,0.0003497756,0.000002046267,0.000019014415,2.7951754e-7,0.00003035217,0.0000049234222,0.9723128,0.0010945639,0.0005478631,0.02558487],"study_design_scores_gemma":[0.00045784033,0.00074076373,0.02230472,0.0000045301817,0.000035255827,0.000012960225,0.00018230572,0.000003904321,0.7508782,0.004393366,0.2207958,0.00019032847],"about_ca_topic_score_codex":0.0000023332495,"about_ca_topic_score_gemma":0.0000073875335,"teacher_disagreement_score":0.22143458,"about_ca_system_score_codex":5.317651e-7,"about_ca_system_score_gemma":0.000027276912,"threshold_uncertainty_score":0.29768962},"labels":[],"label_agreement":null},{"id":"W4393062477","doi":"10.2147/btt.s369783","title":"Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy","year":2024,"lang":"en","type":"article","venue":"Biologics","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Endometrial cancer; Medicine; Identification (biology); Precision medicine; Personalized medicine; Cancer; Translational research; Targeted therapy; Biomarker; Computational biology; Bioinformatics; Biology; Internal medicine; Pathology","score_opus":0.06881452045671953,"score_gpt":0.3414309784189212,"score_spread":0.2726164579622017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393062477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6322033,0.32737172,0.02794241,0.006170358,0.0014366511,0.0030333481,0.00041374937,0.00023665385,0.0011918255],"genre_scores_gemma":[0.987216,0.0075220675,0.004433653,0.00029464165,0.00021374765,0.0001956073,0.000016700937,0.000011863842,0.00009574232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993692,0.000013601903,0.000114135975,0.0002670574,0.00007440768,0.0001615719],"domain_scores_gemma":[0.99966943,0.0001750275,0.00001648933,0.000054084147,0.00003221672,0.00005275528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013447853,0.00010726593,0.00022397774,0.00015382629,0.000020891055,0.000015859594,0.000035021967,0.00008987661,0.0000621704],"category_scores_gemma":[0.00016343044,0.000066685614,0.00007973213,0.00034387357,0.000032768927,0.000020972533,0.000016987682,0.00007394944,0.0000017131256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003348229,0.00054573687,0.0017975866,0.00014014679,0.00049396005,0.0000914355,0.0005991582,0.00000555822,0.72334576,0.051995188,0.000109819965,0.21752742],"study_design_scores_gemma":[0.11749406,0.029221853,0.065341875,0.00082404993,0.0007282389,0.00015477966,0.0031447613,0.0018842546,0.51086897,0.1226867,0.1456997,0.001950774],"about_ca_topic_score_codex":0.00011349514,"about_ca_topic_score_gemma":0.000009139909,"teacher_disagreement_score":0.3550127,"about_ca_system_score_codex":0.00009715817,"about_ca_system_score_gemma":0.0000510091,"threshold_uncertainty_score":0.27193603},"labels":[],"label_agreement":null},{"id":"W4407780132","doi":"10.3390/biologics5010005","title":"Dupilumab for Chronic Obstructive Pulmonary Disease: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Biologics","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Pulmonary disease; Medicine; Intensive care medicine; COPD; Immunology; Internal medicine; Asthma","score_opus":0.04970187042711858,"score_gpt":0.37155866062248233,"score_spread":0.32185679019536373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407780132","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.1742414e-7,0.969741,0.000056263016,0.00016948416,0.0004436176,0.025582459,0.0024811132,0.0001984653,0.0013272662],"genre_scores_gemma":[0.0000035178484,0.9764834,0.0001627162,0.0002362087,0.0005562029,0.010077593,0.0041370187,0.00010479116,0.008238562],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.994723,0.0006692787,0.0016336263,0.0014560982,0.0005483677,0.00096961757],"domain_scores_gemma":[0.99491715,0.0013431268,0.0007844081,0.0018931438,0.00048543466,0.00057673396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006778555,0.0010756353,0.0063725295,0.000388983,0.00020585176,0.000036717294,0.000844754,0.0005950615,0.00023396155],"category_scores_gemma":[0.003626409,0.00072176167,0.002635585,0.0009705578,0.00034005212,0.00007191474,0.00047353437,0.0007624999,0.0001883598],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004433111,0.00015114016,0.0000064117703,0.8342545,0.00058926933,0.0002348543,0.0000013478337,5.5418052e-8,1.5932397e-7,0.0005535592,0.0012125088,0.16295186],"study_design_scores_gemma":[0.00021947235,0.00008309894,0.000059549304,0.59605706,0.011196771,0.00012325909,0.0000072022995,0.00001687095,6.342245e-8,0.00017998322,0.39162228,0.00043442045],"about_ca_topic_score_codex":0.0000032198332,"about_ca_topic_score_gemma":8.7632617e-7,"teacher_disagreement_score":0.39040977,"about_ca_system_score_codex":0.0029340696,"about_ca_system_score_gemma":0.0055694785,"threshold_uncertainty_score":0.99952334},"labels":[],"label_agreement":null},{"id":"W4413941335","doi":"10.3390/biologics5030026","title":"Cypress Pollen-Peach Cross-Reactivity: The Emerging Role of Pru p 7 as a Marker of Severe Allergic Phenotypes","year":2025,"lang":"en","type":"article","venue":"Biologics","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Cypress; Cross-reactivity; Pollen; Phenotype; Reactivity (psychology); Cross reactions; Biology; Botany; Medicine; Immunology; Genetics; Gene; Antigen; Pathology","score_opus":0.012917759381622112,"score_gpt":0.2886305791715239,"score_spread":0.2757128197899018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413941335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92910874,0.0014985444,0.00011507859,0.0007047037,0.00012487649,0.00025807874,0.000013683165,0.000027571274,0.06814873],"genre_scores_gemma":[0.99654126,0.00043812735,0.00020853011,0.000309556,0.000050368573,0.000005495382,0.00002973261,0.0000072274443,0.0024096947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991854,0.00008409683,0.0002737336,0.00017342181,0.00013825666,0.00014512661],"domain_scores_gemma":[0.9992136,0.00015539363,0.00015933387,0.00026770832,0.00017896468,0.000025031744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026222557,0.00011271655,0.0002841458,0.00005404771,0.000074624724,0.000008277215,0.00010408525,0.00012917351,0.00010874834],"category_scores_gemma":[0.00028450647,0.00006796098,0.00009424572,0.00017941617,0.00013925947,0.000034309433,0.00008122824,0.00012155932,0.000004133074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004202677,0.0014550904,0.43849304,0.0006341112,0.0016969452,0.00006273687,0.0050408877,0.0010213585,0.2959114,0.08207873,0.004385019,0.16501799],"study_design_scores_gemma":[0.0033683314,0.00070160907,0.84264207,0.0005149553,0.00026299743,0.00009126813,0.0037063053,0.005174404,0.035885274,0.012339691,0.094893046,0.00042005416],"about_ca_topic_score_codex":0.00015746297,"about_ca_topic_score_gemma":0.0000135730625,"teacher_disagreement_score":0.40414903,"about_ca_system_score_codex":0.000019801058,"about_ca_system_score_gemma":0.000089021894,"threshold_uncertainty_score":0.27713683},"labels":[],"label_agreement":null},{"id":"W4414749562","doi":"10.2147/btt.s547672","title":"Migrasomes: A New Role in Disease Diagnosis and Treatment","year":2025,"lang":"en","type":"review","venue":"Biologics","topic":"Neuroscience of respiration and sleep","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Magna International (Canada)","funders":"","keywords":"Disease; Pathogenesis; Neuroinflammation; Organelle; Cell; Pathological; Signal transduction; Cell type","score_opus":0.13782832250217136,"score_gpt":0.36750087582606916,"score_spread":0.2296725533238978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414749562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002450791,0.998239,0.0000023521197,0.00014926707,0.00018654543,0.0007335851,0.00007170951,0.000047346573,0.00032514508],"genre_scores_gemma":[0.000047349713,0.99729484,0.0000207681,0.000566455,0.000042617583,0.00022285983,0.0000072369444,0.000006856164,0.0017910359],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985504,0.00022125179,0.0002613939,0.0006473924,0.00009148639,0.0002280902],"domain_scores_gemma":[0.99886155,0.0005989951,0.00010385453,0.0002550582,0.0000042233764,0.00017632401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005740436,0.0002740492,0.0006021203,0.00021709813,0.00007061604,0.000078267156,0.0002614308,0.00012197464,0.000020446781],"category_scores_gemma":[0.0011939299,0.00017058771,0.0001649061,0.00049107184,0.000096496704,0.00004961789,0.00009799439,0.000103055085,0.000028469807],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000027077554,0.00007569955,0.0003687162,0.00030803657,0.0000010333196,0.000043135275,0.000011309255,3.196036e-7,0.0000060199113,0.0003717344,0.0001373945,0.9986739],"study_design_scores_gemma":[0.00010978622,0.00011301159,0.000060704657,0.0009092746,0.0000400811,0.000002322872,0.0000026837333,0.0000052464775,0.000017527213,0.00014617432,0.99843055,0.00016265412],"about_ca_topic_score_codex":0.000017881985,"about_ca_topic_score_gemma":0.000023492255,"teacher_disagreement_score":0.99851125,"about_ca_system_score_codex":0.000055629163,"about_ca_system_score_gemma":0.00033084443,"threshold_uncertainty_score":0.69563645},"labels":[],"label_agreement":null}]}